In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.

This content is currently on FREE ACCESS, enjoy another 2 days of free consultation


Prognostic impact of angiographic results in cardiogenic shock

Session Poster Session 3

Speaker Tuija Javanainen

Congress : Heart Failure 2019

  • Topic : coronary artery disease, acute coronary syndromes, acute cardiac care
  • Sub-topic : Coronary Artery Disease: Treatment, Revascularization
  • Session type : Poster Session
  • FP Number : P1787

Authors : T Javanainen (Helsinki,FI), M Banaszewski (Warsaw,PL), J Lassus (Helsinki,FI), M Nieminen (Helsinki,FI), H Tolppanen (Helsinki,FI), T Jantti (Helsinki,FI), A Kataja (Helsinki,FI), M Hongisto (Helsinki,FI), L Kober (Copenhagen,DK), A Sionis (Barcelona,ES), J Parissis (Athens,GR), T Tarvasmaki (Helsinki,FI), V-P Harjola (Helsinki,FI), R Jurkko (Helsinki,FI)

T Javanainen1 , M Banaszewski2 , J Lassus1 , M Nieminen1 , H Tolppanen1 , T Jantti1 , A Kataja3 , M Hongisto3 , L Kober4 , A Sionis5 , J Parissis6 , T Tarvasmaki1 , V-P Harjola3 , R Jurkko1 , 1Helsinki University Central Hospital, Heart and Lung Center, Helsinki University - Helsinki - Finland , 2Institute of Cardiology, Intensive Cardiac Therapy Clinic - Warsaw - Poland , 3Helsinki University Central Hospital, Department of Emergency Medicine and Services, Helsinki University - Helsinki - Finland , 4University of Copenhagen, Department of Cardiology, Rigshospitalet - Copenhagen - Denmark , 5Hospital de la Santa Creu i Sant Pau, Cardiology Department, IIB-SantPau, CIBER-CV, Universitat Autonoma de Barcelona - Barcelona - Spain , 6Attikon University Hospital, ER and Heart Failure Clinic - Athens - Greece ,

On behalf: CardShock



In acute coronary syndrome (ACS) related cardiogenic shock (CS) urgent coronary angiography is essential. The aim was to investigate the association of angiographic results with 90-day mortality in CS patients.


This CardShock (NCT0137486) substudy included 158 patients with ACS aetiology and data on coronary angiography. Survival analysis was conducted with Kaplan-Meier curves and Cox regression analysis.


Median age was 67±11 years and 121 (77%) were men. During the 90-day follow-up 66 (42%) patients died. Patients with one-vessel disease (n=49) had lower mortality than patients with two- (n=59) or three-vessel (n=50) disease (25% vs. 48% vs. 52%, p=0.011, Figure A). Successful revascularization (post-procedural TIMI grade 3 flow) was achieved more often in survivors than non-survivors (81% vs. 60%, p=0.019, Figure B).  Median symptom-to-balloon time was similar between survivors and non-survivors (335 [210-641] min vs. 340 [190-660] min, p=0.70). In multivariable mortality analysis, the CardShock risk score (HR 1.76, CI 1.45-2.13), multivessel disease (HR 2.24, CI 1.13-4.44) and post-procedural TIMI < 3 (HR 1.85, CI 1.08-3.16) were associated with 90-day mortality.


Multivessel disease is associated with worse survival in ACS-related CS. Successful revascularization of the IRA had a positive effect on outcome despite delay from symptom onset.

Based on your interests

Three reasons why you should become a member

Become a member now
  • 1Access your congress resources all year-round on the New ESC 365
  • 2Get a discount on your next congress registration
  • 3Continue your professional development with free access to educational tools
Become a member now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are